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Ever since the demonstration in 1891 by Foa and Carbone, 1 Emme- 
rich  and  Fowitzky,  2 and  G.  and  F.  Klemperer  3 of  the  immunizing 
properties of the serum of animals rendered immune to pneumococcus, 
this serum, modified in various ways, has been employed to a greater 
or less extent in the treatment of pneumonia in man. 
Besides the employment of sera prepared in various ways  in small 
series of cases,  there has  been an  extensive employment of the sera 
prepared according to the directions of Pane, 4 Washbourn, s and more 
lately Rrmer  ~ and  Neufeld and HitndelY, 8  In  this  country at least 
six  commercial  houses  which  sell  biologic products  have  for  some 
years been producing immune serum for the treatment of pneumonia 
and pneumococcus infections.  It  is  impossible  to know how exten- 
sively these sera have been employed, certainly to  a  sufficient extent 
to render their production profitable. 
In  spite  of  all  that  has  been  written  concerning  the  theoretical 
principles  involved  in  the  preparation  of  antipneumococcic  serum, 
and  in  spite  of all  the  reports  of its  therapeutic  application  which 
have appeared, it is very difficult to learn from the literature  on the 
subject exactly how these  sera have been prepared  or standardized. 
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Without this knowledge we can have no accurate starting-point  from 
which to proceed toward improvements in methods of production. 
In view of these facts and also since an antipneumococcic serum is 
now being prepared by The Rockefeller Institute for Medical Research 
and used in the Hospital of this institution, and since serum made in 
a  similar manner is now being preparecl by a number of commercial 
houses  and  by  several  public  health  laboratories  for  wider  dis- 
tribution, it has seemed important that an accurate description of the 
methods employed by  us  in  its  production  be  published,  together 
with  a  brief  discussion  of  the  theoretical  basis  for  the  methods 
employed. 
Theoretical Considerations Concerning the  Production  of 
Antipneumococcic Serum. 
In spite of a  general belief to  the contrary, all kinds of animals, 
even  the  most  susceptible,  may  be  rendered  actively  immune  to 
pneumococcus  infection,  by  the  previous  injection  of  non-lethal 
doses  of living  pneumococci or  even by  the  injection  of  the  dead 
bodies.  Indeed, the substances of the bacteria which give rise to the 
immune reaction are very resistant to various chemical and physical 
agents,  and  a  review of the literature shows that  it  is  possible  to 
produce active immunity with a  great variety of antigens  prepared 
from the bacteria.  The degree of immunity,  however,  differs, de- 
pending upon the procedures employed. 
The  serum  of  the  actively  immunized  animals,  in  many  cases, 
possesses  protective  and  curative power,  the  degree of  this  power 
depending somewhat on the height of the active immunity, but not 
invariably or regularly so.  It may be stated, however, that animals 
whose serum is protective and curative are always actively immune. 
On  the  other hand,  an  animal may itself be  fairly highly immune 
without the serum containing any immune bodies that we can demon- 
strate,  and  without  its having any demonstrable protective action. 
For instance, we have immunized rabbits so that they have success- 
fully withstood 0.1 cc. of a living culture, of which 0.000001  cc. killed 
the control, without the blood showing a  trace of immune bodies  or 
any protective power.  Quite frequently animals whose serum shows 
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to  enormous  doses.  The  fact  that  active  immuni'ty  and  serum- 
immunizing  power do not  run  exactly parallel  does not  necessarily 
indicate  that  active  immunity  in  pneumococcus  infection  differs 
fundamentally  from passive immunity,  but suggests this  possibility. 
At any rate, it suggests that in the reaction of resistance to, or recovery 
from, infection there may be other factors concerned than the humoral 
ones.  Nevertheless,  with  present  knowledge  of  serum  therapy  our 
effort must be confined to the  production  of  a  serum  having  a  high 
content in demonstrable antibodies and a  high protective value.  The 
chief kinds of antibodies which can be demonstrated  in  this  immune 
serum are  agglutinins  and  opsonins or bacteriotropins,  and  the kind 
of protective  power meant  is  that  which  is  exhibited  when  a  very 
small  amount  of  the  serum  is  injected  into  a  susceptible  animal 
such  as the mouse,  simultaneously with,  or within  a  few hours  fol- 
lowing, the injection of a  large dose of virulent  culture,  which alone 
would  cause  rapid  death  of  the  animal.  These  are  the  properties 
of the  serum which are  at present  tested to indicate its  therapeutic 
strength. 
It would lead us far from our present purpose, were we to discuss 
here  at  length  the mode of action  of  the  serum,  for  the  discussion 
would  necessarily  involve  a  consideration  of  the  mechanism  of  re- 
sistailce  and  recovery.  It  is  not  believed  that  the  action  of  the 
immune  serum is  entirely  dependent  either  on its power of causing 
agglutination  (Bull  9)  or  on  its  bacteriotropic  power  (Neufeld  and 
Rimpau  1° and Neufeld and  H~ndel 7, 8), though  these properties may 
play important  parts.  They,  however,  are  susceptible of  quantita- 
tive  estimation.  The  protection  of  small  animals  undoubtedly 
reproduces  more  accurately  the  part  which  the  serum  plays in  re- 
covery from  natural  infection,  as  seen  in  the  human  patient,  but 
even here the conditions are not identical. 
At the present time, however, the effectiveness of the serum seems 
to be parallel to its content in the antibodies we have mentioned, and 
especially to its protective power tested as we have described.  We 
believe  the  production  of  antipneumococcic  serum  that  may  be 
accurately standardized  is of fundamental importance.  Whether  all 
theoretical qualiti~ations are fulfilled is not so essential. 
9 Bull, C. G., J. Exp. Med.,  1916, xxiv,  7. 
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Specificity. 
The primary requisite for the serum is that it is specific.  Every- 
thing  stated  above  concerning  both  active  and  passive  immunity 
is  true  only if  the  bacterium  acted  upon,  either  in  antibody  tests 
in vitro,  or in protection tests in vivo,  is identical with the organism 
used in producing  the serum.  This  does not merely mean  that  the 
bacteria  shall  belong  to  the  same  species,  for  it  is  now  generally 
known that different races of the same species of bacteria may show 
differences in  their  antigenic  properties,  even without  differences in 
their  cultural  characteristics.  These  differences  have  heretofore, 
however,  been  considered  differences merely  in  degree  and  mainly 
in  lesser  degree.  To  overcome the  difficulties which  this  fact puts 
in the way of the production of immune serum for practical purposes, 
recourse has been had  to the method of immunizing  an animal with 
many different strains, producing a polyvalent serum.  This method, 
for  instance,  has  been made  use of  to  a  'considerable  extent  in  the 
production  of  anfimeningococcic serum.  Although  certain  races of 
meningococci differ from each other quite markedly in their immuno- 
logical properties,  yet  they  all  have  common  characteristics  which 
render  a  sharp  differentiation  difficult, if not impossible.  The  con- 
ditions  as regards meningococci at present  seem to be somewhat as 
follows.  If  we  employ  the  Ehrlich  nomenclature,  each  strain  of 
meningococcus is endowed with a large number of kinds of receptors 
which we may designate by the letters of the alphabet.  In one large 
group of strains of meningococcus a receptors predominate; in another 
group b receptors predominate, etc.  In smaller groups other receptors, 
such as k,  l,  m,  or n  receptors,  are most numerous.  However, even 
in the first two groups, the a  and b receptors are not exclusively pres- 
ent  or  even  overwhelmingly  predominating.  Indeed  each  of  the 
different races possesses practically all the different kinds of receptors 
but in greatly  varying degrees. 
Under these conditions, in order to produce a  serum which will be 
active against all the different races it is necessary to choose and employ 
for  immunization  a  large  number  of  races  in  order  that  the  entire 
receptor  "spectrum"  shall  be  covered  as  uniforml,v  as possible.  It 
seems that it is possible to do this fairly well as far as meningococcus 
is concerned. RUFUS  COLE AND HENRY  ~. MOORE  541 
The conditions as concerns pneumococcus are similar, though not 
identical.  From agglutination experiments Kindborg  a  decided that 
all  strains  of pneumococci were immunologically distinct.  Neufeld 
first brought evidence of group relationships and this fact has been 
elaborated and extended by the work in The Rockefeller Institute 
Hospital and elsewhere.  Dochez and  GillespiO  2 have demonstrated 
that the pneumococci obtained from cases of pneumonia occurring in 
this country belong in four large groups.  The immunological charac- 
teristics of the organisms of three of these groups are very specific. 
The  conditions therefore  among  pneumococcus are  different  from 
those  obtaining  among  meningococcus.  It  is  difficult  to  demon- 
strate  by  immunological methods  that  pneumococcus of  Type  I 
has  any immunological characteristics  (or receptors in  the Ehrlich 
nomenclature) which are common to all pneumococci.  Complement 
fixation tests, however, seem to  show that the pneumococci of the 
different types do possess  some common characters,  at  least  these 
tests are not absolutely specific as regards the different types (Hanes  ~") 
and the antihemolytic reactions of specific sera against the hemolytic 
toxins derived from different types of pneumococci (ColO  4)  are not 
absolutely specific.  So too the extremely active agglutinating immune 
sera produced by the injection of pneumococci of specific  types may 
have slight degrees of effectiveness against  certain  strains  of  other 
types  (BlakOs).  But in  general the different types of pneumococci 
have a high degree of specificity as shown by protective action and by 
agglutination.  Active immunity to  the  different types  also  seems 
very specific.  This type specificity, which was only lately recognized, 
is of fundamental and primary importance in considering the practical 
application of immunity to therapy in this disease.  Since nothing was 
known of this group specificity before the observations of Neufeld were 
made, it is very difficult to draw any  conclusions from the observa- 
tions or from  the results of their practical  application which were 
made in  this  field before  that  time.  Where identical strains  were 
11 Kindborg, A., Z. Hyg. u. Infectionskrankh.,  1905, li, 197. 
12 Dochez, A. R., and Gillespie,  L. J., J. Am. Mecl. Assn., 1913, lxi, 727. 
13 Hanes, F. M., Y. Exp. Med., 1914, xix, 38. 
14 Cole, R., Y. Exp. Meal., 1914, xx, 346. 
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used  throughout experiments,  the  conclusions of course were valid, 
but in the absence of knowledge of the importance of using only these 
strains,  it  is  probable  that  in  many cases  this  procedure  was  not 
strictly adhered to. 
The work done in the Hospital of The Rockefeller Institute, both 
experimentally and clinically, indicates that immune serum against 
Type I  infection is more effective than that against any other of the 
specific types.  Indeed the results obtained both here  and elsewhere 
indicate that this serum has great therapeutic value when it is em- 
ployed in the treatment of cases due to the same type of pneumococcus. 
On  the other hand,  the observations which have so  far been  made 
with sera of the other types do not show that these produce distinct 
therapeutic effects.  It is possible,  of course,  that improvements in 
the method  of  production  or  mode  of  application of  these  other 
types  of  serum  may  lead  to more  satisfactory  results.  For  the 
present,  however,  we believe  that  the general practical  application 
of this form of therapy should be confined to Type I  cases, and this 
may readily be  done  since  the  type of  infection in  the  individual 
case may easily be  determined by the methods described elsewhere 
(Blake10.  We also think it important at present that the commercial 
production  of  antipneumococcic serum for therapeutic purposes  be 
confined to that effective against Type I infection.  This paper aims 
to present the best method for manufacturing this serum and is based 
on the experience we have gained through the immunization of a very 
large  number  of rabbits,  several  goats,  and  four horses  to  Type  I 
pneumococcus,  four  horses to  Type  II pneumococcus, one to Type 
III  pneumococcus, and one to  both Type  I  and  Type II  pneumo- 
cocci, or ten horses in all. 
Animals to Be Employed for Immunization Purposes. 
For practical reasons small animals cannot be used to supply serum 
for  therapeutic  purposes,  especially if  the  large  amounts of serum 
which are now considered necessary are to be used. 
In the earlier therapeutic tests, such as those of G. and F. Klemperer and Foa 
and Carbone, rabbits were used for obtaining the small amounts of serum used. 
Later Washbourn used ponies for immunizing  purposes.  Pane used a cow and 
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RSmer  s has laid stress oa the importance of combining the sera prepared by 
immunizing a number of different animals.  His reason for this is a purely the- 
oretical one;  namely, that  all the different antigenic elemertts contained  in  a 
complex structure  such as the paeumococcus may not fmd suitable receptors in 
any one animal.  With  present knowledge it  seems that we may disregard this 
consideration. 
We believe that for practical reasons it is best to use horses.  Our 
experience is not sufficient to enable us to have a  definite opinion  as 
to the kind of horses best to choose for this purpose; apparently, how- 
ever, draft horses are  superior to the lighter  grades and to the more 
finely bred animals.  Joint injuries,  indeed injuries of all kinds,  un- 
doubtedly contribute to  the  localization  of  pneumococcus and  con- 
sequent focal infection.  The highly strung, nervous horses are more 
liable to these injuries and infections.  These accidents delay immuni- 
zation.  As  regards  antibody  response,  there  has  been  marked  in- 
dividual  variation,  but  the  difference has  not  been  associated with 
any obvious distinction in type of horse.  In rabbits, with which our 
experience  is much larger,  there  is very great  individual  difference. 
It is far more important in the production of this kind of serum than 
in the production of antitoxic sera that the horses should be perfectly 
sound and healthy, especially without old joint injuries. 
Site of Injection. 
Neufeld has laid stress on the value of intravenous injections.  We 
have  also  employed  this  method  since  local  reactions  are  thereby 
avoided.  With  dead  cultures  the  local  reactions  are  usually  not 
severe or  important;  where  living  cultures  are  employed,  however, 
they may be violent and  abscess formation not infrequently occurs. 
It is felt, moreover,  that  by intravenous  injections  the bacteria  are 
brought more rapidly and quickly and with less opportunity for change 
into contact with widely distributed cells, the  reaction with which is 
supposed to result in the immunity response. 
Choice of Antigen. 
Use of Living or Dead Cultures.--As we have previously stated, the 
production  of active immunity is attended  with little  difficulty and 
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but  when we  come to  the  question  of  the  production  of humoral 
immunity, especially of the highest grade, this factor may be of the 
greatest importance.  It has generally been assumed on  theoretical 
grounds  that  to  produce  the  highest  grade  of  humoral  immunity 
it is  necessary to .use living  cultures.  It seems  likely  that  all  the 
various constituents of the bacterial cell and even some products of 
growth, which may be  very labile, give  rise  to  specific  antibodies. 
Therefore to  obtain  the  most  varied  and  complete reaction it has 
been  thought  necessary to employ the living organisms, which may, 
for a short time at least, grow in the body and produce or give rise by 
their  dissolution  to  certain labile metabolic substances  which  may 
stimulate antibody formation.  Most  of  the  anfipneumococcic sera 
which have been prepared, at least of late years, have been produced 
by the injection first of dead, then of living organisms.  The general 
acceptance of this method is probably due in part to what is known 
concerning immunity in tuberculosis.  Here, as is well known, the only 
immunity that is effective has been produced by the injection of living 
organisms, by producing a mild tuberculous infection.  One must be 
careful, however, in applying what is known concerning one type of 
infection directly to another, without due consideration.  As knowl- 
edge of infection increases it becomes more  and  more  evident  that 
each disease must be considered independently.  As  we  shall  show 
later, it is possible that in the production of antipneumococcic serum 
the living organisms are not so  important  as  they have previously 
been considered. 
Virulence  of  Organisms Employed.--Pneumococci may  rapidly 
lose their virulence for animals when grown in an artificial medium. 
This loss of virulence, however, may not be uniform for all kinds of 
experimental  animals.  Moreover,  the  virulence  of  pneumococci 
which have long been grown on artificial media may be increased by 
passing  repeatedly through  experimental animals.  Here  again  the 
increase  of  virulence may not  be  uniform for  all  the  varieties  of 
animals.  It is possible, for instance, to obtain a  given strain which 
is  very  virulent  for  guinea  pigs,  with  little  virulence  for  rabbits. 
Even for animals as closely related in their susceptibility to pneumo- 
coccus infection as the rabbit and mouse, it is possible to have races 
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It is manifest, therefore, that we can judge only very imperfectly of the 
virulence of a  given race for man by determining its virulence for a 
susceptible  animal,  such  as  the mouse or  rabbit.  Whether in  the 
production of an immune serum it  is  important, for  the organisms 
employed to be highly virulent or not is not known.  Neufeld and 
his  associates  7. 10  have  laid  stress  on  the  employment of  virulent 
cultures, believing that the action of immune serum is to neutralize 
exactly those  receptors of the bacterium upon which virulence de- 
pends.  They state  that they have proved experimentally that im- 
munity cannot be produced with avirulent races, but give no protocols. 
Races virulent for mice have been employed in all our immunizing 
studies and we have no observations concerning immunization  with 
avirulent  races.  If  virulence  of  the  organism used  as  antigen  is 
important, what we have just stated concerning virulence for different 
species of animals becomes of great  significance.  It will be remem- 
bered that mice are used in all our tests of immunity.  The fact that 
a  serum is protective for mice would indicate that it had been pro- 
duced by a race of pneumococci virulent for mice, but the test might 
give us little information relative to its  protective power for man. 
We have therefore come to believe, on these purely theoretical grounds, 
that the immunization of horses should be carried on with organisms 
which  have  not  been  long  under  artificial  cultivation  since  their 
isolation  from  the  human  body.  These  organisms  are  practically 
always virulent for mice, so that where they are employed, the test 
of the protective power of the serum in mice is probably a good test 
for protective and curative power in man.  In order to have a culture 
which has not long been removed from the human body always ready 
for use, advantage may be taken of an observation made by Heim  ~6 
and confirmed by Neufeld and H~indeF and abundantly corroborated 
by us; namely, that when pneumococci are preserved in pieces of dried 
tissue  or blood  they remain viable  for a  very long  time,  and  also 
retain their virulence undiminished.  For preserving small amounts 
of culture the spleens of infected mice, dried and kept in a  vacuum, 
are most satisfactory.  For preserving large amounts of culture from 
human patients, it is well to inoculate a  rabbit with blood or other 
infected  material.  After  infection  has  reached a  maximum grade, 
is Helm, L., Z. Hyg. u. Infectlonskrankh.,  1905, l, 123. 546  PRODUCTION  OF  ANTIPNEUMOCOCCIC  SERUM 
the  rabbit  is  bled  and  the  blood is  spread  in  thin  layers  in  Petri 
dishes and dried.  To obtain a  fresh culture at any time  all that  is 
necessary is to inoculate a  little of this  dried material  into  the peri- 
toneal cavity of a mouse and later make a fresh culture from the heart's 
blood.  For  immunizing  purposes  a  fresh  culture  obtained  in  this 
way should be prepared  every 1 or 2 weeks.  This precaution in ob- 
taining  cultures  should be taken  not only when the live bacteria are 
to be injected, but also when dead organisms are to be employed. 
Method  of  Growing  Organisms  Used  for  Injection.--The  use  of 
bacteria grown in broth and separated by centrifugaiization from the 
medium  in  which  they  are  grown  was first  employed by Neufeld  t7 
who believed that the substances formed in the medium during growth 
are not useful but indeed harmful.  We also think that it is not neces- 
sary to use the  fluid  in  which  the bacteria  are  cultivated.  In  this 
belief we differ from Wadsworth  18 whose observations apparently show 
that  the serum produced with  whole  cultures is more effective than 
that produced by the injection of the bacteria alone.  His experiments, 
however, are not entirely conclusive and in the absence of any method 
of accurately titrating  this  increased  efficacy, it  does not  seem  ad- 
visable to employ the whole culture.  Moreover, the injection of the 
whole culture adds greatly to the difficulty of the immunizing process. 
As  is  well  known,  even  fresh  bouillon  is  toxic  and  after  bacterial 
growth has taken place it is still more toxic.  In using whole cultures, 
therefore, one is much  restricted  as to the amount that can safely be 
injected.  When the amount of culture to be injected reaches  a large 
size, the technical difficulties and time required in centrifugalizing  the 
cultures become considerable.  We have attempted to overcome these 
difficulties  by  growing  the  pneumococci  on  blood  glucose  agar  in 
flasks and washing off the surface growth in salt solution,  using the 
emulsion  so  obtained,  without  centrifugalizing.  For  certain  the- 
oretical  reasons,  moreover,  we  thought  this  method  might  be  of 
advantage.  In  our experience,  however,  the method  of growing  in 
bouillon  and  centrifugaiizing  still  proves  the  most  satisfactory.  In 
our earlier  work the  organisms  were obtained by growing in  broth, 
1~ Neufeld, F., Z. Hyg. u. Infectionskrankh., 1902, xl, 54. 
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centrifugalizing,  and  washing  once  in  salt  solution,  and  then  re- 
suspending in salt solution.  In our later work, however, we have not 
thought it  necessary to  wash,  but have merely centrifugalized and 
then made an emulsion of the sediment in salt solution. 
For obtaining a satisfactory growth in bouillon the reaction of the 
medium is of great importance.  Pneumococci grow best in a medium 
the reaction of which is 0.3 to 0.5 per cent acid to phenolphthalein.  If 
the reaction is more acid than this, a satisfactory growth may not be 
obtained.  We have added no sugar, serum, or other enriching sub- 
stance to the medium employed. 
Size and Spacing of Doses. 
In our first studies we employed the method which has been largely 
employed by others, making the injections every 7 to 8 days.  This is 
the method generally employed in immunization and  has developed 
from the observation that the most efficient stimulus can be applied 
at the time when the immunological response to the preceding dose 
is  most  active.  Grades  of  high  immunity  have  been  thought  to 
increase in a  step-like manner, each increment being added to  that 
previously  present.  It  is  again  not  certain,  however,  that  anti- 
pneumococcus  immunity  obeys  the  same  laws  as  other  forms  of 
immunity in which this step-like rise occurs.  Certain of our observa- 
tions  to  be mentioned later indicate  that  even when the injections 
are made at the period of greatest activity, instead of a  rise in the 
immunity, there may be a  fall, especially if the dosage is  too large. 
After a  primary immunity had been obtained by weekly injections 
of dead cultures, live organisms were injected, beginning with small 
doses, i.e., the bacteria from 2  to  5  cc.  of bouillon culture, and the 
succeeding weekly injections were gradually increased in size up  to 
the bacteria contained in 1 or even 2 liters of culture.  Neufeld speaks 
of injecting doses of living pneumococci as large as the bacteria ob- 
tained from  1,500  cc. of culture in  the horse,  and from 3,500  cc. in 
the ass.  He  injected  doses of  dead organisms as  large as  the bac- 
teria contained in 9 liters of culture.  In our experience this method 
of  immunization is  attended with many disadvantages.  It has re- 
quired  6  to  8  months  to  bring horses up  to  the  desired  grade  of 
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by the following protocol of a  horse  in  which  the  attempt  was  made 
to  produce  an  effective  serum  by  using  only  small  doses  of culture 
(Table  I). 
TABLE  I. 
Horse  1.  Immunized  to  Pneumococcus  Type  I. 
Date.  Injection.  Tests of serum. 
1916 
Feb.  2 
o:  4 
"  11 
"  18 
"  26 
Mar.  3 
"  11 
"  19 
"  29 
Apr.  3 
"  15 
"  22 
"  22 
May  7 
3,250 units of tetanus  antitoxin  subcutaneously. 
Bacteria from  25 cc. of culture, killed by heating. 
"  "  50"  "  "  "  "  " 
"  "  75  "  "  ....  "  " 
"  living, from  2.5 cc. of culture. 
5.0  ~  ~c  ~c 
10.0 "  "  " 
20.0 "  "  " 
40.0  "  "  " 
80.0 "  "  " 
Bacteria,  living, from 120 cc. of culture. 
Agglutination:* complete. 
Protection:t  0.1  cc.,  D.; 
0.01 cc. S. 
Agglutination:*  complete. 
Protection:t 0.1 cc.,  S. 
* These tests were made before we commenced the routine accurate titration 
of the agglutination strength. 
t In the protection tests each of the mice received 0.2 cc. of serum simultane- 
ously with a graduated dose of culture, both given intraperitoneally.  The figures 
given  indicate  the  amount  of  culture  added.  D.  indicates died;  S., survived. 
For brevity, only the highest dose with which recovery took place is given.  In 
all cases the control animals receiving 0.000001  cc. of culture alone died. 
It is true  that  the results  obtained  with  this  horse were unusually 
good, better than any we have since been able to obtain with a  similar 
method.  They  indicate,  however,  that  the  large  doses  which  we 
had been using were not necessary, that equally good results could be 
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Modification  and Improvements  in the Methods  of Immunization. 
Over a  year ago we undertook experiments  to  determine whether 
or not animals could be immunized more rapidly than had been done 
in the past, and also whether it might not be possible to obtain a higher 
grade of immunity than we had previously observed,  and finally to 
determine for ourselves whether the use of living organisms  is neces- 
sary in producing humoral immunity. 
To determine the best methods of immunization a large number of 
rabbits  was  immunized  in  various  ways  and  the  development  of 
immunity  studied.  Certain  observations  which  had  been  made 
indicated  that  the  process  might  be  hastened  by  more  frequent 
injections of antigen than had previously been used. 
In 1900 Dean  19 showed that in the production of diphtheria antitoxic immunity 
the administration of the toxin at 3 day intervals gave very successful and practical 
results.  Daily doses of antitoxin have been administered with good results when 
other methods have failed. 2°  In  1908 Fornet and  Mtiller 21  showed  that  pre- 
cipitating sera could be produced very rapidly by three daily injections of antigen, 
bleeding on the 12th day.  Bonhoff and Tsuzuki  ~  confirmed these observations 
and Tsuzuki  e3 showed that  by a  similar  method a rapid production of typhoid- 
agglutinating serum could be produced.  Similar  observations  have been made 
by Gay and his assistants. 24 
Flexner and Amoss  ~s have employed a  similar  method in the  production of 
antidysenteric serum, injecting live cultures on 3 successive days, with excellent 
results.  In  the same  way the method of three daily injections has been em- 
ployed by Amoss and Wollstein ~-s in the production of antimeningococcic serum. 
In the production  of  antidysenteric  and  antimeningococcic  serum 
stress has been laid on regulating the size of the dose so that, follow- 
ing each inoculation, a  febrile reaction shall be obtained.  It occurred 
to  us  that  the  choice of three  daily  doses  had been made  more  or 
19 Dean, G., Tr. Path. Soc. London, 1900, li, 15. 
2o Personal communication from Dr. Theobald Smith. 
~1 Fornet, W., and Mtiller,  M., Z. biol. Techn. u. Method., 1908--09, i, 201. 
2~ Bonhoff, H., and Tsuzuki, M.,  Z.  Immunit~tsforsch., Orig., 1909-10, iv, 180. 
2~ Tsuzuki, M., Z. Immunit~tsforsch., Orig., 1909-10, iv, 194. 
~4 Gay, F. P., Ergebn. Immunitatsforsch. exp. Therap., Bakteriol. u. ttyg., 1914, i, 
231. 
~s Flexner, S., and Amoss, H. L,, J. Exp. Med., 1915, xxi, 515. 
zs Amoss, H. L., and Wollstein,  M., J. Exp. Med., 1916, xxiii, 403. 550  PRODUCTION OF ANTIPN'EUMOCOCCIC SERUM 
less  arbitrarily  and  that  possibly  daily  doses  administered  over  a 
longer time might be still more efficacious in producing a satisfactory 
result,  especially  since  this method had proved of value in the pro- 
duction of diphtheria antitoxin.  That this method is indeed of much 
value is seen from the results of the experiments  given below.  The 
experiments  need  not  be  described  here  in  detail.  Certain  slight 
variations  due to external causes were made in individual instances, 
but most of the animals were treated about as follows. 
Series/.--These animals  received weekly intravenous  injections of large amounts 
of  bacteria obtained by centrifugalization of  broth  cultures, which were  then 
killed by heating for  1  hour  at  56°C.  The  size of  the doses varied from the 
bacteria contained in 100 cc. of broth to those contained in 500 cc. 
Series 2.--These animals received intravenous injections of very small amounts 
of bacteria killed by heat as in the above experiment; the doses were given daily 
for 7 days, then an interval of 7 days was allowed to elapse, and a second series of 
injections was given, etc.  The bacteria in the individual doses varied from those 
contained in 1 cc. of broth to those contained in 2 cc. 
Series 3.--These animals received combined doses of immune horse serum  and 
living cultures intravenously, beginning  with 1 cc. of serum plus 0.1 to 0.5  cc.  of 
culture.  This dose was repeated every day for 3 days, then 7 days were allowed 
to elapse, and a second series of these combined doses was given, this time using 
slightly larger doses  of  culture.  After an  interval of  another week,  combined 
doses using still larger amounts of culture were given, etc. 
Series 4.--These animals received varying sized doses  of  pneumococci killed 
by the addition of 0.5 per cent carbolic acid.  The bacteria were centrifugalized 
from broth cultures, taken up in salt solution, the carbolic acid was added, and 
the mixture kept at 37°C. over night.  As in the preceding series,  the  injections 
were  given  intravenously  on 3 successive days, then an interval of a  week was 
allowed to elapse, and the second series given.  The number of bacteria in tbe in- 
dividual doses varied from  those  contained in 2 cc. of broth to those in 50 cc. of 
•  broth.  Some animals received large weekly doses subcutaneously. 
Series f--These animals received injections of an antigen prepared as follows. 
The bacteria were grown in broth,  centrifugalized, washed,  and taken up in a 
very small amount of salt solution, and this emulsion was added to a large amount 
of acetone.  The sediment which formed was centrlfugalized at once, dried in a 
vacuum, and after 12 hours in the v~cuum, taken up in salt solution and thoroughly 
shaken.  From this somewhat viscid translucent fluid further dilutions in salt 
solution were made.  The injections in these rabbits were  made once a  week, 
and the doses  varied from an amount of antigen representing the bacteria con- 
tained in 5  cc. of broth to one representing the bacteria contained in 220 ce. of 
broth.  The small doses were given intravenously,  the larger ones subcutaneously. RUFUS  COLE  AND  HENRY  ~'.  MOORE  551 
In addition to the above, a small series of rabbits received injections 
of antigen prepared by freezing and grinding the bacteria, and another 
small series received injections of bacteria dissolved in bile. 
In studies such as these it must be borne in mind that individual 
rabbits immunized in exactly the same way may show quite marked 
variations in their immunity response.  Slight differences, therefore, 
in results obtained in small series of animals are not of significance. 
It would lead us too far to attempt to analyze in detail the results 
in  the various tests or  to  publish the protocols.  One definite fact 
stands out from these studies.  Uniformly the results following the 
injection of small doses of killed culture given daily over a period of 
7 days followed by 7 days of rest were excellent (Series 2).  This is 
in marked contrast to the results obtained by the injection of large 
doses of killed cultures given at intervals of a week (Series 1).  Serum 
from these animals showed little or no evidence of immunity.  This is 
strikingly shown in Table II. 
TABLE  II. 
l  Weight.  Agglutination [  Protection  Date.  Day.  Injection.  tests.,  tests. 
Rabbit 1. 
1916 
May 27 
June  4 
"  14 
"  24 
July  1 
1 
7 day in- 
terval. 
9 
9 day in 
terval. 
19 
day in- 
terval. 
29 
5 day in- 
terval. 
36 
gm. 
1,670 
1,400 
1,300 
1,270 
1,150 
Bacteria from 250 cc. of culture, 
killed by heating. 
Bacteria from 250 cc. of culture, 
killed by heating. 
Bacteria from 250 cc. of culture, 
killed by heating. 
Bacteria from 250 cc. of culture, 
killed by heating. 
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TABLE ll--Continued. 
Weight.  Agglutination  Protection  Date.  Day.  Injection.  tests,  tests. 
Rabbit 2. 
1916 
May 28 
"  29 
"  30 
"  31 
June  1 
~  2 
June  10 
"  11 
"  12 
"  13 
"  14 
"  15 
June 23 
"  24 
"  25 
"  26 
"  27 
July  6 
gm, 
1,520  Bacteria from  1 cc.  of culture 
killed by heating. 
Bacteria from  1  cc.  of culture 
killed by heating. 
Bacteria from  1  cc.  of culture 
killed by heating. 
Bacteria from  1  cc.  of culture 
killed by heating. 
Bacteria from  1  cc.  of culture 
killed by heating. 
Bacteria from  1 cc.  of culture, 
killed by heating. 
1,650] 
1,180 
1,100 
Bacteria from  1 cc.  of culture, 
killed by heating. 
Bacteria from  1 cc.  of culture, 
killed by heating. 
Bacteria from  1 cc.  of culture, 
killed by heating. 
Bacteria from 1  cc.  of culture, 
killed by heating. 
Bacteria from  1  cc.  of culture, 
killed by heating. 
Bacteria from  1  cc.  of culture, 
killed by heating. 
Bacteria  from  1  cc.  of culture, 
killed by heating. 
Bacteria from  1 cc.  of culture, 
killed by heating. 
Bacteria from  1  cc.  of culture, 
killed by heating. 
Bacteria from  1  cc.  of culture, 
killed by heating. 
Bacteria  from  1  cc.  of culture, 
killed by heating. 
1:200 -'k 
1:400  0 
0.2 cc., D. 
0.1cc.,S. RUFUS  COLE  AND  HENRY  F.  MOORE  553 
As the protocols show the serum of Rabbit  1 injected weekly with 
large doses of culture showed no agglutinating power and only moder- 
ate protective action.  On  the other hand,  the serum of Rabbit  2 
which  was  treated  over  practically  the  same  period  of  time  but 
received very small daily doses showed high agglutinating strength, 
positive in  a  dilution of 1:200,  and high protective power.  These 
results  were  most  surprising  and  striking,  especially as  all  of  the 
eight rabbits inoculated with the small daily doses showed an extra- 
ordinarily prompt and active response, while all of the eight rabbits 
inoculated with the large doses showed very little or no response in 
the same period of time. 
The  studies  of  other  methods  of  immunization  gave  little  in- 
formation.  The attempts to produce immunity with combined doses 
of  serum  and  culture  (Series  3)"gave  unsatisfactory results.  The 
experiments  of this series were undertaken because by  this method 
live  cultures  could be  injected at  the very beginning  of  the  im- 
munization.  Moreover,  Theobald  Smith  27  and  von  Behring  28 have 
shown  the  possibility  of  immunizing  with  combined  doses  of 
toxin  and  antitoxin.  Besredka  ~°  and  others  have  shown  the  pos- 
sibility of  immunizing  against  typhoid  with  sensitized  cultures. 
Levy and Aoki  ~° claim to have produced immunity to pneumococci 
with great rapidity (in 6 hours) by the injection of sensitized bacteria 
killed with carbolic acid.  However, in view of what is now  known 
concerning possible  dissociation of pneumococcus antigen and  anti- 
body (Gay and Chickering~'), it is possible that what the latter writers 
observed was not active immunity but slight  grades  of passive  im- 
munity.  In any case,  the grade of immunity produced  was  slight. 
Our experiments yielded no evidence in favor of the combined injec- 
tion of culture and immune serum.  Nevertheless, it is possible that 
other modifications of the method might yield better results, especially 
as we made no effort to balance accurately the amounts  of  culture 
and immune serum employed. 
~7 Smith, Theobald, J. Med. Research, 1907, xvi, 359. 
~8 von Behring, E., Deutsck. reed. Woch., 1913, xxxix, 873. 
~o Besredka, cited by Gay.  24 
3o Levy, E., and Aoki, K., Z. Imrauni~tsforsch., Orig., 1910, vii, 435. 
31 Gay, F. P., and Chickering,  H. T., J. Exp. Med., 1915, xxi, 389. 554  PRODUCTION  OF  ANTIPNEUMOCOCCIC  SERUM 
The serum of the rabbits of Series 4 inoculated with cultures killed 
by carbolic acid indicated no considerable grade of immunity.  There 
is apparently  no advantage  to be gained  in employing  antigen  pre- 
pared in this way.  Levy and Aoki,  3° however, have reported the pro- 
duction  of immune  serum  in  dogs  by the  use  of  this  method;  but 
the grade of immunity, according to our standards, was slight. 
Finally, the experiments in Series 5 and  those in which frozen and 
ground bacteria and bacteria dissolved in bile were employed simply 
offer observations  in  the  use of  bacterial  antigenic  substances  pro- 
duced in other ways. 
Neufeld  ~2 and Vetrano  38 have also employed bile extracts of pneurnococci for 
immunizing purposes, only,  however, in  the  production  of  active  immunity. 
Others  have  employed  still  other  artificial methods  of  treating  the bacteria. 
G. and F. Klemperer  3  used glycerol extracts and  Wadsworth  TM attempted immuni- 
zation with cultures precipitated with alcohol and dissolved in water. 
These and our own observations with artificially produced antigens 
show that slight grades of immunity can be produced by antigens pre- 
pared  by  various  methods.  The  antigenic  substance  seems  to  be 
highly resistant.  However, n~either the observations of others nor our 
own indicate that these methods are especially useful in extracting the 
antigenic  substance or in rendering  it more effective.  Indeed in all 
instances  the  immunity  reaction  resulting  from  the  employment  of 
antigens prepared in these ways was less intense  than  that  following 
the injection  of heat-killed  bacteria.  One  fact  emerges  from  these 
experiments,  however, though in a  less striking  way  than  from  the 
observations previously mentioned; namely, that small doses repeated 
frequently are much more effective than  large doses given at longer 
intervals.  The  very large  doses seem  to  have  a  definite  repressing 
action on the development of antibodies. 
These observations led us to immunize a series of four rabbits with 
small  daily doses to  determine  the exact time  of appearance  of the 
immune properties in the serum.  Table III is a  typical protocol of 
one  of  the  rabbits. 
33 Neufeld, Z. Hyg. u. Infectionskrankk.,  1900, xxxiv, 454. 
8~ Vetrano, G., Centr.  Bakteriol., lte Abt., Orig., 1909, lii, 275. TABLE  III. 
Rabbit  3. 
Date. 
1916 
May 29 
"  29 
"  30 
"  31 
June  1 
"  2 
"  3 
"  9 
"  11 
"  12 
"  13 
"  14 
"  15 
"  16 
"  23 
"  24 
"  25 
"  26 
"  27 
"  28 
"  29 
July  5 
"  7 
Weight. 
gm. 
1,950 
1,950 
1,900 
1,910 
1,900 
1,750 
1,750 
1,900 
1,850 
1,950 
Injection of 
vaccine. 
1" 
1 
1 
1 
1 
1 
Agglutination 
tests. 
1:1  ++ 
1:10  0 
1:1  ++ 
1:10 ++ 
1:20  + 
1:100 ++ 
1:200  + 
1:400  0 
Protection tests. 
0.0001  cc., D. 36hrs. 
0.00001  "  "  36  " 
0.000001  "  "  36  " 
0.1  co., D. 16 hrs. 
0.01  "  "  79  " 
01001  "  S. 
0.0001  ~'  " 
0.1  cc., S. 
0.01  "  " 
0.001  "  " 
0.2 cc., D. 20 hrs. 
0.1  "  S. 
0.01"  " 
* In these experiments the material for injection was prepared at the beginning 
of the experiment and kept on ice.  150 cc. of an 18 hour broth culture of Pneu- 
mococcus Type I  was centrifugalized and the sediment washed once in salt solu- 
tion.  The sediment was taken up in  10  cc.  of salt solution and heated i  hour 
at 56°C.  Cultures were sterile.  The emulsion was kept on ice and, after shak- 
ing,  a  small  amount  was  removed and  diluted  to  original volume before each 
injection.  The injections were made intravenously. 
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The experiment shows that it is possible by this method of immuni- 
zation  to  produce  a  high  grade  of immunity within 6  weeks;  even 
within 4  weeks a  considerable grade of immunity is  present.  The 
serum  from  each  of  the  four  rabbits  showed  a  high  agglutinating 
titer and  a  constant  protective  power  against  0.01  to  0.1  cc.  of 
culture.  Two of the rabbits lost slightly in weight, one remained sta- 
tionary, and one actually gained.  They showed no other ill effects. 
Experiments have also been made to show whether similar or better 
results could be obtained by injecting animals daily with small doses 
over  longer  periods  than  7  days.  Four  rabbits  were  given  small 
daily doses for 14 days and then bled and the serum was tested on the 
5th and  10th days following the last injection.  The serum of these 
TABLE  IV. 
Horse  2.  Immunized  to  Pneumococcus  Type  I. 
Date.  Injection.  Agglutination  Protection tests 
test. 
1916 
an.  27 
"  29 
"  30 
"  31 
Feb.  1 
"  2 
"  3 
"  10 
"  11 
"  12 
"  13 
"  14 
"  15 
"  23 
"  24 
"  25 
"  26 
"  27 
"  28 
Mar.  8 
1,500 units of tetanus, antitoxin subcutaneously. 
Bacteria from 50 cc. of culture, killed by heating. 
"  "  50  "  "  "  "  "  " 
"  "  50  "  "  "  "  "  " 
"  "  50  "  "  "  "  "  " 
cc  cc  50  "  "  ~c  ~c  .  ~c 
"  "  50  "  "  "  .  cc  . 
"  "  50  "  "  "  "  "  " 
.  cc  50  "  "  "  "  "  " 
cc  "  50  "  "  "  cc  ~c  ~c 
"  "  50  "  cc  .  cc  .  . 
~c  c¢  50  cc  c¢  ¢C  ~  CC  cc 
.  ~c  50  "  ~c  ~c  cc  .  cc 
c~  cc  50  ~  ~  cc  ~c  cc  ~c 
"  "  50  "  "  "  "  "  " 
.  cc  50  "  "  cc  .  .  . 
1:200 +  0.1 cc., S. 
0.1  "  D. 
0.01 "  S. RUFUS  COLE  AND  ItENRY  F.  MOORE  557 
animals has shown very slight agglutinating and protective power, so 
that this modification seems to be of no advantage. 
The results of the rabbit experiments have led us to try  the  method 
of  immunization  described  above  in  horses.  The  result  obtained  in 
one horse treated in this manner  is given in Table IV. 
The  results in this and other horses have  shown  that  it is possible 
in this way to produce a  very high grade of primary  immunity  with a 
great saving in time and without  danger to the  animal.  The  dosage 
has been  arbitrarily chosen.  It  is possible that  with further  experi- 
ence and more carefully regulated dosage it may be possible to produce 
even higher grades of immunity  in this way.  It may even be possible 
by this method  to obviate entirely the use of live cultures. 
What  has been attempted  so far, however, has been the production 
of  a  primary  immunity  in  the  quickest  possible time  and  with  the 
least loss in horses. 
TABLE  V. 
Horse  2,  Undergoing  Immunization  Since  January  29,  1916.  Last  Bleeding,  11 
Liters,  on  May  15,  1917. 
Date.  Injection.  Protection  tests. 
1917 
May 26 
"  27 
"  28 
"  29 
"  30 
June  1 
"  9 
"  11 
"  14 
"  15 
"  16 
"  17 
June 25 
July  6 
a  7 
,c  8 
"  13 
Bacteria from 100 cc. of culture, killed by heating. 
"  "  100 "  "  "  "  "  " 
"  "  100  "  "  "  "  "  " 
"  "  100  "  "  "  "  "  " 
"  "  100  "  "  "  "  "  " 
"  "  100  "  "  "  "  "  " 
"  "  100  '~  ,c  ,,  ~  ,,  ,c 
"  "  100  "  "  "  "  "  " 
"  "  100  "  "  "  "  "  " 
"  "  100  "  "  "  "  "  " 
"  "  100  "  "  "  "  "  " 
"  "  100  "  "  "  "  "  " 
Blood test. 
Bacteria, living, from 100 cc. of culture. 
"  "  "  130  "  "  " 
"  "  "  160  "  "  " 
Blood test. 
0.01 cc., D. 
0.2 cc., S. 558  PRODUCTION  OF  ANTIPNEUMOCOCCIC  SERUM 
The  problem  now confronting  us  is  to  determine  the  method  by 
which horses having an established primary immunity may be brought 
up to the highest possible level and kept there.  In order to do this, 
when dead cultures have failed, it may be necessary to resort to living 
.~_~4~6~9~  9 ~.t2i14~  i6  7  9,~4 
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TExT-FIG. 1.  Temperature curve of Horse 3 injected with living Pneumococcus 
Type I. 
cultures.  An observation on one of our horses makes  this probable 
(Table  V). 
In  this horse, whereas repeated small daily doses of killed culture 
failed  to  bring  the  serum  up  to  full strength,  three  moderate  sized 
doses of living culture caused the serum to acquire maximum power. RD'I~US  COLE  AND  HENRY  ~'.  MOORE  559 
This  result has been seen on numerous occasions and it is probable 
that in most horses living cultures must finally be employed.  When 
injections  of  living  cultures  are  made  we  now  employ the  method 
described  by  Flexner  and  Amoss,  ~5  administering  three  doses  in 
amounts sufficient to produce a  moderate febrile reaction.  A typical 
curve  is  shown in  Text-fig.  1.  So  far  as pneumococcus immunity, 
however,  is  concerned,  the  necessity for producing  febrile  reactions 
is  not  established.  Neufeld  believed  that  so  far  as  agglutinating 
sera are  concerned the power depends not so much on the height of 
the immunity as on the intensity of the last reaction through which 
the animal had passed.  Therefore he  thought it advisable  to inject 
as large amounts  as possible without killing the animal.  The obser- 
vations we have made do  not  support  this  point of  view.  In  our 
experience with horses a violent reaction is  not always followed by a 
marked immunity response or increase in  agglutinating power  of the 
serum; indeed the  opposite is frequently the  case.  For the present, 
however, in giving live cultures it is probably better to be guided  in 
the  size  of  the  dose  by the  febrile  reactions.  We think, however, 
that large doses should be  avoided even though the febrile reaction 
is  slight. 
Typical Method of Immunization Based on Previous Observations. 
As a  result of our observations and those of others we now  believe 
that immunization should  be  carried  out  according  to  the  method 
as at present employed by us, which is briefly given below. 
Having obtained a sound, fairly heavy horse, it is first given a glanders test. 
At present  the complement  fixation test is used for this purpose.  A specimen 
of 20 cc. or more of blood is obtained before  any treatment is given and is kept 
for use in control  tests.  The immunization  is thei/carried out as follows.  All 
injections  are made intravenously,  employing  for  this purpose a  Luer  syringe. 
To avoid any accidental injury to the vein it is well to have the needle attached 
to the syringe with a small piece of rubber tubing.  The culture used for injec- 
tion, whether living or dead, should be one highly virulent for mice, 0.000001 cc. 
killing regularly,  and it should have gone through very few passages in animals 
or on artificial media since removal  from the human patient.  The method for 
keeping  the cultures  is described  above  (page 545).  In preparing  the material 
for injection,  both living and  dead, the organisms are  grown on beef  peptone 
broth, reaction  0.3 to 0.5 per cent acid to phenolphthaiein.  Cultures  about 12 560  PRODUCTION  OF  ANTIPNEUMOCOCCIC  SERUM 
to 15  hours old are preferable as  at this time maximum growth is present, with 
a minimum of autolysis (Chesney*4).  The cultures should contain about 200 to 
300 million bacteria per cc.  The culture is centrifugalized until the supernatant 
fluid  is clear.  With the  large  centrifuge  employed by  us  this  requires  about 
20 to 30 minutes.  The supernatant fluid is then poured off and the sediment is 
taken up in a  small amount  of sterile salt solution. 
If the organisms are to be injected alive, the emulsion in salt solution is not 
made until just before injection, so that autolysis and death may not take place. 
If the organisms are to be injected dead, the emulsion is placed in a  tube in a 
water bath and kept at 56°C. for { hour.  For the daily injections a  considerable 
amount of the emulsion, after killing, is prepared and kept on ice.  This may be 
employed for all the injections in the series of 6 to 7 days.  We think, however, 
a  fresh emulsion should be prepared each week.  For each injection the dilution 
of the fluid should be such that  the  volume injected is about 20 cc. 
The following course of injections is now carried out.  Every day for 6 days 
an amount  of the emulsion of killed pneumococci containing the  bacteria from 
5C cc. of the bouillon culture is injected.  An interval of 7 days is allowed to elapse 
and then a  second series of daily injections, of the same size, is made.  Again an 
interval is allowed to elapse and on the 6th day a specimen of blood is obtained 
for  testing.  Tests  are  made  at  once  for  agglutinating  and  protective power. 
This requires several days. 
If the serum causes agglutination in a  dilution of 1:200 and  is  of  standard 
protective value, 0.2  cc. regularly protecting a  mouse against 0.1  cc. of a  virulent 
culture, bleeding may be carried out at once; that is, on the  10th to  12th  day 
following the last injection.  As a matter of fact, we have never seen the titer of 
the serum after this amount of treatment to be so high.  Consequently it has been 
our practice, and we advise, that 8 to 10 days after the last injection of the second 
series of dead bacteria, injection of live organisms be commenced.  These injec- 
tions are given on successive days.  The first injection should consist of the bac- 
teria contained in 20 cc. of the original culture.  The temperature is taken every 2 
hours for 8 to 10 hours  following each of the injections of live cultures.  If the 
temperature reaction is only moderate, not over 40.5°C., an injection of the bac- 
teria from 40 cc. of culture is given on the following day.  If the reaction from this 
is only moderate, the dose is again doubled on the following day and the bacteria 
from 80 cc.  of  culture are injected.  As before stated,  so  far as  pneumococci 
are concerned it is difficult to regulate the dosage entirely by the febrile reaction 
obtained.  If the reaction is very severe, of course the dose is made smaller than 
those mentioned.  On the other hand, even though the reaction is very slight, we 
do  not advise giving more than  the amounts stated.  6  days after the last in- 
jection another specimen of blood is obtained for testing.  If the serum is of the 
standard strength,  bleeding can now be done.  If it is still too weak, a  second 
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series of injections  of living  bacteria  is made.  These injections  should  consist 
of the bacteria from 100 cc., 150 cc., and 200 cc. of broth on the 3 days respectively. 
Again, the size of the doses may need to be somewhat modified, on account  of 
the severity or  lack of febrile reaction.  Certain  horses  may require  still  fur- 
ther injections of live cultures but this is exceptional.  In any case, we thank the 
injections should  be made in series  of three, given on successive days, with 7 
day intervals between each series, and from our present  standpoint we believe 
that the size of the injection should never be greater than  the bacteria from 
300  to 400  cc.  of broth.  Following the bleeding, it is well to allow the horse 
to remain quiet for 3 or 4 days.  Then a series of three injections  of living cul- 
tures, 50, 80,  and  100 cc., is  again given.  Mter a  week  the serum is again 
tested and if of standard strength bleeding may again be done on the 10th day 
following the last injection. 
CONCLUSIONS. 
In the production of immune serum for therapeutic purposes strict 
attention must be paid to the immunological specificity of the bacteria 
used  for  immunization.  At  present  the  only  serum  of which  the 
therapeutic value has been proven is  that effective  against  Type  I 
pneumococcus  infection.  This  serum  should  have  agglutinating 
power  for  Type  I  pneumococcus  and  should  have  the  power  of 
protecting mice against large  amounts of  virulent culture.  Experi- 
ments have shown that for producing the primary immunity most rap- 
idly several series of small doses of dead cultures should be given, the 
injections being made daily for 6 to 7 days, followed by a week in which 
no injections are made.  To produce the highest type of immunity prob- 
ably living organisms are required.  These should be given in moderate 
doses daily for 3 days, with an interval of a  week between each series 
of injections.  By following accurately the methods described, horses 
may be  made  to  produce  rapidly  a  high  grade  of  specific  serum. 
The observations  so  far made indicate  the  importance of employing 
small doses of culture frequently repeated in this form of immunization. 